ARCHIVES

Avastin Loses Indication for Breast Cancer

This article is from The Cancer Letter archive.

Vol. 37 No. Nov 18 special report | November 18, 2011

Download PDF Visit The Full Archive

Related Articles

Patent Policies Need Revision, Study of Hopkins, CellPro Dispute Concludes;

January 10, 2003

NCAB Needs Focus, Strong Membership To Better Advise NCI, Chairman Rimer Says

September 22, 1995

Deborah Mayer Appointed To NCAB; Cancer Panel Plans Meetings For July 9

May 10, 1991

In Breif: FDA Issues Uterine Cancer-Tamoxifin Warning; Fisher Declined Invitation To Speak At AACR

April 15, 1994

Avastin Approved To Treat Progressive Glioblastoma

May 29, 2009

Reviewers Note Major Flaws In Design Of Burzynski’s Trials

September 25, 1998